News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Co-analysis of Methylation Platforms for Signatures of Biological Aging in the Domestic Dog

News

July 23, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 13, entitled, “Co-analysis of methylation platforms for signatures of biological aging in the domestic dog reveals previously unexplored confounding factors.” continue reading »

Oncotarget Welcomes New Editorial Board Members

News

July 22, 2024
Oncotarget is also offering a 50% discount on publication fees until the end of the year. continue reading »

Improved Efficacy of Pembrolizumab When Combined With sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC

News

July 22, 2024
PRESS RELEASE: On July 10, 2024, a new research paper was published in Oncotarget, entitled, “Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.” continue reading »

DDX41 and Its Unique Contribution to Myeloid Leukemogenesis

News

July 19, 2024
PRESS RELEASE: On July 2, 2024, a new editorial was published in Oncotarget, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.” continue reading »